Literature DB >> 17967847

Assessment of coronary artery bypass grafts by magnetic resonance imaging.

N I Stauder1, B Klumpp, H Stauder, G Blumenstock, M Fenchel, A Küttner, C D Claussen, S Miller.   

Abstract

This study evaluated graft patency and flow at rest/stress in patients with coronary artery bypass grafts using MR flow measurements and MR angiography (MRA). 45 symptomatic patients with 86 grafts (46 arterial, 40 venous) were examined 5.5 years after surgery. MRA was used to assess bypass patency. Flow measurements were performed at rest and after stress induction with dipyridamole. All graft segments were evaluated at MRA for stenosis, and were additionally evaluated by the combination of flow measurements and MRA. Conventional coronary angiography or multidetector computed tomography was regarded as a reference standard. No significant stenosis was observed in 49 grafts (Group A), whereas significant stenosis was observed in 37 grafts (Group B). Sensitivity, specificity, and positive and negative predictive values for stenosis in arterial grafts were 95.2%, 96.8%, 80% and 99.4%, respectively, and in venous grafts were 100%, 97.8%, 87.5% and 100%, respectively. The mean blood flow rate at baseline/stress in Group B was significantly lower than that in Group A (p<0.002/p<0.001). With the combined MR method, 84 of 86 (97%) grafts could be correctly classified. In conclusion, MRI allows a combined assessment of graft status, including bypass patency and flow, in symptomatic patients after revascularization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967847     DOI: 10.1259/bjr/26167398

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  1 in total

1.  Diagnostic accuracy of 64-slice CT in evaluating coronary artery bypass grafts and of the native coronary arteries.

Authors:  A Romagnoli; A Patrei; A Mancini; C Arganini; S Vanni; M Sperandio; G Simonetti
Journal:  Radiol Med       Date:  2010-09-17       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.